To verify whether CCL20-modulated PMN-MDSCs promoted stemness of breast cancer cells via CXCL2-CXCR2 axis, 4T1 or Py8119 cells were treated with recombination mouse CXCL2 protein (rmCXCL2) for three days. The gene discussed is CXCL2; the disease is breast carcinoma.